Study of FID-022 in Participants With Advanced Solid Tumors

NCT06694480 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Fulgent Pharma LLC.